Skip to main content
. Author manuscript; available in PMC: 2020 Jun 15.
Published in final edited form as: Clin Cancer Res. 2008 May 1;14(9):2681–2689. doi: 10.1158/1078-0432.CCR-07-1760

Table 2.

Cox regression analysis of OS in entire cohort (n = 96)

OS in entire cohort
Univariate
Multivariate*
HR (95% CI) P HR (95% CI) P
CNR (<5 vs >5) 0.1 (0.01–0.73) 0.023 0.09 (0.01–0.76) 0.027
Nodal status (positive vs negative) 3.03 (1.48–6.20) 0.002 2.71 (1.18–6.24) 0.019
Grade (1 and 2 vs 3) 2.52 (1.32–4.81) 0.005 0.65 (0.27–1.55) 0.330
ER status (positive vs negative) 0.38 (0.20–0.73) 0.004 0.58 (0.20–1.72) 0.338
Her2 (1 and 2+ vs 3+) 2.19 (1.06–4.52) 0.034 2.04 (0.81–5.15) 0.129
PR status (positive vs negative) 0.41 (0.21–0.80) 0.009 0.85 (0.35–2.07) 0.727
Tumor size (continuous) 1.04 (1.02–1.06) 0.001 1.05 (1.02–1.08) 0.002
Ki-67 (0–10% vs 11–100%) 2.60 (1.01–6.67) 0.047 0.98 (0.31–3.10) 0.975
p53 (0–10% vs 11–100%) 2.19 (1.15–4.17) 0.017 0.93 (0.34–2.51) 0.882
*

Adjusted for all other variables in the table.